Polymyxin B/pulmonary surfactant mixtures have increased resistance to inactivation by meconium and reduce growth of gram-negative bacteria in vitro

Pediatric Research

Volumn 59, Issue 3, 2006, Pages 407-411

  Stichtenoth, Guido ^a   Jung, Philipp ^b   Walter, Gabi ^b   Johansson, Jan ^c   Robertson, Bengt ^a   Curstedt, Tore ^a   Herting, Egbert ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHLORIDE; LUNG SURFACTANT; POLYMYXIN B; PORACTANT; BIOLOGICAL PRODUCT; PHOSPHOLIPID;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CROSS LINKING; DRUG ADSORPTION; DRUG INACTIVATION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MECONIUM; MECONIUM ASPIRATION; NEWBORN DISEASE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; ANIMAL; HUMAN; METABOLISM; SURFACE TENSION; SWINE;

ANIMALS; BIOLOGICAL PRODUCTS; CALCIUM CHLORIDE; GRAM-NEGATIVE BACTERIA; HUMANS; MECONIUM; PHOSPHOLIPIDS; POLYMYXIN B; PULMONARY SURFACTANTS; SURFACE TENSION; SWINE;

EID: 33646106806     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000200806.32822.e6     Document Type: Article

References (40)

1. Moses D, Holm BA, Spitale P, Liu M, Enhorning G 1991 Inhibition of pulmonary surfactant by meconium. Am J Obstet Gynecol 164:477-481
2. Sun B, Curstedt T, Song GW, Robertson B 1993 Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate 63:96-104
3. Findlay RD, Taeusch HW, Walther FJ 1996 Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 97:48-52
4. Herting E, Rauprich P, Stichtenoth G, Walter G, Johansson J, Robertson B 2001 Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 50:44-49
5. Johansson J, Curstedt T, Robertson B 2001 Artificial surfactants based on analogues of SP-B and SP-C. Pediatr Pathol Mol Med 20:501-518
6. Mifsud AJ, Efstratiou A, Charlett A, McCartney AC; Health Protection Agency Group B Streptococcus Working Group 2004 Early-onset neonatal group B streptococcal infection in London: 1990-1999. BJOG 111:1006-1011
7. Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ 2004 Features of invasive staphylococcal disease in neonates. Pediatrics 114:953-961
8. Cordero L, Rau R, Taylor D, Ayers LW 2004 Enteric Gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit. Am J Infect Control 32:189-195
9. Herting E, Sun B, Jarstrand C, Curstedt T, Robertson B 1997 Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia. Arch Dis Child Fetal Neonatal Ed 76:3-8
10. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B 2000 Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics 106:957-964
11. Evans ME, Feola DJ, Rapp RP 1999 Polymyxin B sulfate and colistin: old antibiotics for emerging rnultiresistant Gram-negative bacteria. Ann Pharmacother 33:960-967
12. Zaltash S, Palmblad M, Curstedt T, Johansson J, Persson B 2000 Pulmonary surfactant protein B: a structural model and a functional analogue. Biochim Biophys Acta 1466:179-186
13. Enhorning G 1977 Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 43:198-203
14. Notter RH, Tabak SA, Mavis RD 1980 Surface properties of binary mixtures of some pulmonary surfactant components. J Lipid Res 21:10-22
15. Rebello CM, Jobe AH, Eisele JW, Ikegami M 1996 Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med 154:625-628
16. Schmalisch G, Wauer RR 1993 [Percentile curves of functional residual capacity of newborn infants.] Monatsschr Kinderheilkd 141:714-720
17. Brace RA, Wolf EJ 1989 Normal amniotic fluid volume changes throughout pregnancy. Am J Obstet Gynecol 161:382-388
18. Aziz S, Leroy P, Servaes R, Eggermont E, Fevery J 2001 Bilirubin-IXbeta is a marker of meconium, like zinc coproporphyrin. J Pediatr Gastroenterol Nutr 32:287-292
19. Calkovska A, Some M, Linderholm B, Johansson J, Curstedt T, Robertson B 2005 Biophysical and physiological properties of porcine surfactant enriched with polymyxin B. Biol Neonate 88:101-108
20. Kobayashi T, Shido A, Nitta K, Inui S, Ganzuka M, Robertson B 1990 The critical concentration of surfactant in fetal lung liquid at birth. Respir Physiol 80:181-192
21. Taeusch HW 2000 Treatment of acute (adult) respiratory distress syndrome. The holy grail of surfactant therapy. Biol Neonate 77:2-8
22. Sun B, Curstedt T, Robertson B 1993 Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 82:182-189
23. Tashiro K, Cui XG, Kobayashi T, Curstedt T, Robertson B 2003 Modified protocols for surfactant therapy in experimental meconium aspiration syndrome. Biol Neonate 83:49-56
24. William Taeusch H, Lu KW, Goerke J, Clements JA 1999 Nonionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 159:1391-1395
25. Lu KW, Goerke J, Clements JA, Taeusch HW 2005 Hyaluronan decreases surfactant inactivation in vitro. Pediatr Res 57:237-241
26. Sun B, Curstedt T, Lindgren G, Franzen B, Alaiya AA, Calkovska A, Robertson B 1997 Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. Eur Respir J 10:1967-1974
27. Schurch S, Qanbar R, Bachofen H, Possmayer F 1995 The surface-associated surfactant reservoir in the alveolar lining. Biol Neonate 67:61-76
28. Cajal Y, Ghanta J, Easwaran K, Surolia A, Jain MK 1996 Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts. Biochemistry 35:5684-5695
29. Veldhuizen EJ, Batenburg JJ, van Golde LM, Haagsman HP 2000 The role of surfactant proteins in DPPC enrichment of surface films. Biophys J 79:3164-3171
30. Rauprich P, Moller O, Walter G, Herting E, Robertson B 2000 Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period. Clin Diagn Lab Immunol 7:817-822
31. Bryan SC 1967 Enhancement of bacterial infection by meconium. Johns Hopkins Med J 121:9-13
32. Florman AL, Teubner D 1969 Enhancement of bacterial growth in amniotic fluid by meconium. J Pediatr 74:111-114
33. Eidelman AI, Nevet A, Rudensky B, Rabinowitz R, Hammerman C, Raveh D, Schimmel MS 2002 The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B streptococcus. J Perinatol 22:467-471
34. Lembet A, Gaddipati S, Holzman IR, Berkowitz RL, Bottone EJ 2003 Meconium enhances the growth of perinatal bacterial pathogens. Mt Sinai J Med 70:126-129
35. Horton J, Pankey GA 1982 Polymyxin B, colistin, and sodium colistimethate. Med Clin North Am 66:135-142
36. Marier JF, Brazier JL, Lavigne J, Ducharme MP 2003 Liposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in rats. J Antimicrob Chemother 52:247-252
37. Omri A, Suntres ZE, Shek PN 2002 Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Biochem Pharmacol 64:1407-1413
38. McAllister SM, Alpar HO, Brown MR 1999 Antimicrobial properties of liposomal polymyxin B. J Antimicrob Chemother 43:203-210
39. Morrison DC, Jacobs DM 1976 Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818
40. Augusto L, Le Blay K, Auger G, Blanot D, Chaby R 2001 Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol Lung Cell Mol Physiol 281:776-785